GENT — Gentian Diagnostics ASA Balance Sheet
0.000.00%
- NOK838.98m
 - NOK761.88m
 - NOK152.07m
 
- 48
 - 13
 - 78
 - 40
 
Annual balance sheet for Gentian Diagnostics ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
C2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 158 | 115 | 81.6 | 87.6 | 84.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.2 | 22.6 | 19.2 | 17 | 31.3 | 
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 194 | 167 | 139 | 142 | 162 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25.6 | 19.5 | 21.6 | 18 | 14 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 235 | 212 | 188 | 181 | 230 | 
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.6 | 22.6 | 22 | 25.3 | 30.1 | 
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 40.7 | 37 | 33.6 | 34.4 | 35.6 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 195 | 175 | 154 | 147 | 194 | 
| Total Liabilities & Shareholders' Equity | 235 | 212 | 188 | 181 | 230 | 
| Total Common Shares Outstanding |